The Gastric Volvulus Treatment by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Gastric Volvulus Treatment Market:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
According to The Business Research Company’s Gastric Volvulus Treatment, The gastric volvulus treatment market size has grown strongly in recent years. It will grow from $25.6 billion in 2023 to $27.18 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to advancements in surgical techniques, improved diagnostic technologies, awareness and education, rise in minimally invasive procedures, research and clinical studies.
The gastric volvulus treatment market size is expected to see strong growth in the next few years. It will grow to $34.63 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to regulatory changes and approvals, innovations in surgical procedures, growing geriatric population, customized treatment plans, adoption of advanced imaging techniques.. Major trends in the forecast period include minimally invasive surgical techniques, awareness and early intervention, research in treatment modalities, collaborative medical practices, customized treatment approaches.
A rising geriatric population is expected to propel the growth of the gastric volvulus treatment market going forward. The geriatric population refers to older adults 65 years and beyond. The geriatric population suffers from various diseases due to low immunity and age. Gastric volvulus occurs in older adults over the age of 50, hence, the rise in the geriatric population is expected to propel the market. For instance, in November 2022, according to America's Health Rankings, a US-based partnership between the United Health Foundation and the American Public Health Association, in 2021, more than 55.8 million people aged 65 and above were present in the United States, accounting for nearly 16.8% of the total population. Therefore, rising geriatric populations are driving the gastric volvulus treatment market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp
The gastric volvulus treatment market covered in this report is segmented –
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Top Major Players:
- PAI Pharma
- Sun Pharmaceutical Industries Ltd.
- ANI Pharmaceuticals Inc.
- Fresenius SE and Co. KGaA
- Mayne Pharma Group Limited
North America was the largest region in the gastric volvulus market in 2023.
Product innovations are a key trend gaining popularity in the gastric volvulus treatment market. Major companies operating in the market are introducing innovative products to sustain their position in the gastric volvulus treatment market. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved VELSIPITY (etrasimod). VELSIPITY (etrasimod) is a once-daily oral sphingosine-1-phosphate (S1P) receptor activator for people with moderate to severe active ulcerative colitis (UC). VELSIPITY's official suggested dosage is 2 mg. ELSIPITY allows adults with moderately to severely active UC to achieve steroid-free resolution with an oral, once-daily pill that has a positive benefit-risk profile. The FDA's approval of VELSIPITY today marks an important turning point for UC patients who require novel therapies for this long-term illness and are ready to begin advanced therapy.
The gastric volvulus treatment market report table of contents includes:
1. Executive Summary
2. Gastric Volvulus Treatment Market Characteristics
3. Global Gastric Volvulus Treatment Market Trends And Strategies
4. Gastric Volvulus Treatment Market - Macro Economic Scenario
5. Global Gastric Volvulus Treatment Market Size and Growth
…….
26. Global Gastric Volvulus Treatment Market Competitive Benchmarking
27. Global Gastric Volvulus Treatment Market Competitive Dashboard
28. Key Mergers and Acquisitions In Gastric Volvulus Treatment Market
29 Gastric Volvulus Treatment Market Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The gastric volvulus treatment market report has been prepared to bring about comprehensive analysis of the market structure along with forecast of the different segments and sub-segments of the market.
The gastric volvulus treatment market report has been formulated to bring about comprehensive analysis of the market structure along with forecast of the different segments and sub-segments of the market.
Analysis of consumer needs by major regions, types, applications in Global market by considering the past, present and future state of the industry has been conducted.
The report is prepared based on the market type, size of the organization, availability on-premises and the end-users’ organization type.Global gastric volvulus treatment market is expected to grow at a steady CAGR in the forecast period of 2019-2026.
Rise in cases of congenital hernia conditions and high demand of novel therapies is driving the growth of this marketThis gastric volvulus treatment market research report is generated by using integrated approaches and latest technology for the best results.
Analysis and estimation of important industry trends, market size, and market share are mentioned in this gastric volvulus treatment report.
Global Metastatic Gastric Cancer Treatment Market: OverviewGastric cancer (GC) is the second-leading cause of cancer-related mortality worldwide and is also responsible for a significantly high cancer burden, as measured by disability-adjusted life years lost.
The World Health Organization estimates that in 2018, gastric cancer accounted for 783,000 deaths worldwide.
Approximately 50 to 65% of GC patients present with locally advanced or metastatic disease, and the majority would have systemic disease at some time during the course of their illness.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=80552Gastric cancer incidence and mortality are highly variable by region and highly dependent on diet and Helicobacter pylori infection.
In developed countries, gastric cancer is 2.2 times more likely to be diagnosed in males than females.Key Drivers and Restrains of Global Metastatic Gastric Cancer Treatment MarketFavorable reimbursement in developed countries, adoption of combination therapy such as chemotherapy with immunotherapy drugs that effectively work in the stage III or IV gastric cancer.
Doctors are also opting for chemotherapy before surgery, called neoadjuvant therapy, or after surgery, called adjuvant therapy to treat metastatic gastric cancer, which is likely to drive the metastatic gastric cancer treatment market.However, low survival rate of metastatic gastric cancer and high cost associated with the immunotherapy treatment procedures are likely to restraint the market during the forecast periodRequest COVID Analysis on Metastatic Gastric Cancer Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=80552North America to Account for Major Share of Global Metastatic Gastric Cancer Treatment MarketIn terms of region, the global metastatic gastric cancer market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & AfricaNorth America is projected to dominate the global market during the forecast period.
The region is anticipated to account for a significant share of the global market due to wide availability of immunotherapy drugs and favorable reimbursement scenario.The market in Asia Pacific is driven by sustainable growth trends across all clinical fields in countries in the region and consequent increase in number of cases.
Keen learning arrangements use visual components, like diagrams, pictures, graphs, and introductions, to assist understudies with getting a handle on the idea speedier.
This, thus, helps fabricate the premium degree of understudies in the subject understudies; consequently, they adapt successfully and are equipped for holding more data.
It likewise functions as a directing power in honing the innovative creative mind force of understudies.Gastric Lavage Market needs to incorporate the segment, cutthroat, and business data, alongside the client’s information, to discover the complexities.
Associations are attempting to zero in on breaking down the deals and different business sectors to distinguish the holes.
Clients these days have become brand cognizant.
They request better quality, lower costs and quicker conveyance of items and administrations.
